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ABSTRACT 
Cellular adaptation to microbial stresses has been demonstrated in several cell types. 
Macrophages (MФ) are sentinel immune cells fending off invading microbes. Anthrax 
lethal toxin (LeTx) is a key virulence factor released by Bacillus anthracis  that causes 
rapid cell death, pyroptosis. A small number of RAW246.7 macrophages (~4%) exposed 
to a non-lethal dose of LeTx become resistant to LeTx-induced pyroptosis for ~ 4 weeks, 
termed “toxin-induced resistance (TIR)”. Here, I showed that high levels of DNA methyl 
transferase1 (DNMT1) expression were maintained although global genomic methylation 
levels were not high in TIR. TIR cells treated with the DNMT inhibitor 5-azacitidine or 
(si)RNA targeting DNMT1 became susceptible to LeTx-induced pyroptosis. Knocking 
down DNMT1 also increased expression of the mitochondrial cell death proteins Bnip3 
and Bnip3L involved in pyroptosis. However, DNA methylation of CpG islands in Bnip3 
and Bnip3L were not different between wild type and TIR cells. Among histone 
modification genes examined, histone deacetylase (HDAC) 8 was up-regulated in TIR 
cells. The HDAC inhibitor panobinostat or siRNAs against HDAC8 rendered TIR cells 
sensitive to LeTx-induced pyroptosis and induced Bnip3 and Bnip3L expression. 
Acetylation of histone H3 lysine 27 (H3K27Ac) leads to binding of BNIP3 to H3, but this 
association was decreased in TIR cells. Also treatments of panobinostat or 5-azacitidine 
enhanced the levels of H3K27Ac in TIR cells. Collectively, these results suggest that TIR 
was maintained by multiple epigenetic mechanisms through up-regulating expression of 
DNMT1 and HDAC8. This resulted in decrease of H3K27Ac and subsequently 
suppressed the expression of BNIP3.  
 
Keywords 
Bacillus anthracis, anthrax, lethal toxin, toxin induced resistance, epigenetics, DNA 
methylation, histone deacetylation, DNA methyl transferase1, Histone deacetlyase 8 
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CHAPTER 1 - INTRODUCTION 
1.1 Anthrax 
Anthrax is an acute disease caused by the Gram positive bacterium Bacillus anthracis (B. 
anthracis).  B. anthracis forms a dormant endospore (referred to as spore) in harsh 
conditions and can be revived after decades or even centuries after forming spores
1, 2
. The 
spores germinate after being phagocytosed by macrophages, and toxins expressed after 
germination lead to a systematic immune paralysis, shock, and death
3
. Due to their 
stability and obnoxious nature to humans, anthrax spores have been used as a biological 
weapon. A recent example is the incident that occurred in the United States in 2001. 
Anthrax spores packaged in postal letters were sent to several news media offices and 
two democratic senators, resulting in 22 infections and 5 deaths
4
.  In Canada, anthrax 
outbreaks have been reported mainly in the southern portions of Ontario and Quebec 
during the early 1950’s. These regions were often associated with pastures contaminated 
by effluent from textile industries dealing with imported animal materials
5
. In 1952, 
introduction of federal regulations requiring disinfection of these materials greatly 
reduced the incidence of anthrax
6
. In 2006, there was a major outbreak in Saskatchewan
7
 
where dozens of farms were under quarantine and over 200 animals were affected by the 
disease. Anthrax can be acquired by any of three known routes: cutaneous (most frequent 
and less dangerous), gastrointestinal (rare) and inhalational (rare and extremely 
dangerous).
8
  
1.1.1 Cutaneous and gastrointestinal routes 
Cutaneous anthrax is caused when the spores enter through cuts on the skin, often after 
handling infected animal products. After deposition of spores through abrasion on the 
skin, spores geminate in skin tissues and local edema causes the formation of a papule 
that resembles a pimple
9
. Within a few days, the papules develop into fluid filled vesicles 
and form a painless necrotic ulcer with a black center, termed eschar. The eschar dries 
overtime and finally falls off, leaving a scar. Cutaneous anthrax is rarely fatal, if treated, 
because the infection is limited to the skin
10
. However, without treatments, about 20% of 
cutaneous skin infection can progress to toxemia and death.  
 2 
 
Gastrointestinal anthrax develops a few days after ingesting spore-contaminated meat 
from infected animals
11
. It is generally a result of pre-existing lesions in the upper or 
lower gastrointestinal tract, where entry of spores and vegetation of bacteria are possible. 
Symptoms of an upper gastrointestinal infection can include oral or esophageal ulceration 
leading to the development of regional lymphadenopathy, edema, and sepsis
12, 13
. 
Gastrointestinal infections can be treated but usually result in fatality rates of 25~ 60%, 
depending upon the time of initial treatments with antibiotics.  
1.1.2 Inhalation route 
Inhalation of anthrax spores is considered to be extremely dangerous with a 92% 
mortality rate without treatments, but this can be decreased to 45% after rapid treatment 
with antibotics
14
. Inhaled spores are phagocytosed by alveolar macrophages or 
pulmonary dendritic cells, and carried to the mediastinal lymph node via the lymphatic 
system
2, 14
. Spores can remain dormant up to 60 days before germinating and, once 
germinated, first phase clinical symptoms including malaises, mild fever, and a mild 
cough are manifested. In the second phase, bacteria frequently overcomes the lymph node 
filter, and enter the lymphatic and blood circulation, rapidly causing massive bacteremia 
and toxemia
15
. This stage is accompanied by major symptoms including fever, enlarged 
lymph nodes, pulmonary edema with acute dyspnea (labored respiration), and cyanosis 
(bluish discoloration of the skin caused by poor blood oxygenation). The time course of 
this second phase is rapid enough such that antibiotics are no longer effective and death 
caused by shock is followed. It is believed that the shock is mainly caused by secreted 
toxins from live bacteria
15, 16
.  
1.1.3 Treatments & prevention  
Early commencement of treatment is essential for anthrax infections because it increases 
chances for survival. Similar to other bacterial infections, treatments of anthrax include 
large doses of intravenous and oral antibiotics including fluoroquinolones, doxycycline, 
erythromycin, vancomycin, and penicillin. There have been many attempts to develop 
new drugs against anthrax since existing drugs are not effective enough if treatment is 
delayed. In May 2009, Human Genome Sciences submitted an application for its new 
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biologic drug, raxibacumab (brand name ABthrax) indicated for emergency treatment of 
inhaled anthrax
17
. It is a monoclonal antibody that neutralizes anthrax toxins that can 
cause massive and irreversible tissue injury and death. On Dec 2012, the US Food and 
Drug Administration (FDA) approved raxibacumab injection to treat inhalation anthrax
17
.  
 
1.2. B. anthracis toxins 
B. anthracis produces two anthrax toxins, edema toxin (EdTx) and lethal toxin (LeTx), 
derived from the combination of three different factors:  protective antigen (PA; 83 kDa), 
edema factor (EF; 89 kDa) and lethal factor (LF; 90 kDa) 
18
. It has been reported that 
LeTx and EdTx are required for survival of spore and responsible for eventual death of 
infected hosts
3
. PA functions as a molecular transporter, facilitating the entry of LF and 
EF into cells through endocytosis. Assembly of toxin complexes begins after PA binds to 
cellular receptors and is cleaved into two fragments by furin-like proteases
19
. To date, 
two host receptors, the tumor endothelial marker (TEM8) and the cellular receptor 
capillary morphogenesis gene 2 (CMG2), have been identified to bind PA
20, 21
. The 
current model of toxin entry indicates that full length PA (83 kDa) binds to TEM8 or 
GCM2 and is cleaved by furin-like protease at the plasma membrane, leaving cleaved 
large form of PA (PA
63
; 63 kDa) attached to the receptors. Dissociation of the cleaved 20 
kDa fragment allows PA
63 
to form a spontaneous heptameric homo-oligomer that binds to 
EF or LF. PA
63
-EF or –LF complexes induce a lipid raft-mediated clarthrin-dependent 
endocytosis
21
. Once the endosomes are acidified, the complex undergoes conformational 
changes, resulting in the insertion of a flexible loop of each PA molecule into the lipid 
bilayer and the translocation of EF and LF into the cytosol
22
.  There are two virulence 
factors which confer pathogenicity of B. anthracis: a poly D-glutamic acid capsule and 
anthrax exotoxins
23
. These factors are encoded by two different plasmids (pXO1 & 
pXO2)
19, 23
. The poly-D glutamic acid capsule encoded in pXO2 whereas LeTx and EdTx 
are encoded by pXO1. 
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1.2.1. EdTx 
EF is a Ca
2+
-calmodulin-dependent adenylate cyclase that causes a prolonged increase of 
cytosolic cyclic adenosine monophosphate (cAMP)
24
. This is a representative example 
showing how bacteria can successfully evolve to disrupt a wide array of physiological 
processes. EF plays a crucial role in survival of anthrax bacteria in macrophages and 
modulation of the cytokine secreted by human monocytes. EF also collaborates with LF 
and PA to cause toxemia in the host, leading to death
3
. Recent studies showed that EdTx 
alone can cause widespread tissue damage, multi-organ failure and even death in 
BALB/cJ mice
24
.  
1.2.2. LeTx 
LF is a zinc-dependent metalloprotease that cleaves the N-terminal end of mitogen 
activated protein kinase kinases (MEK)1 to 7, except MEK5, resulting in the inactivation 
of these kinases
8
. LF is composed of an N-terminal PA binding domain, a central 
substrate binding domain and a C-terminal catalytic domain. LeTx targets MEKs and 
cleaves several N-terminal acid residues of MEKs, and therefore MEKs cannot escape LF 
recognition through mutation without severe consequences in terms of cell physiology
25
. 
LeTx is the major contributor of anthrax progress in infected animals: LeTx alone can 
provoke various symptoms manifested in actual infections; the chemical LF inhibitors 
protect animal from anthrax
26
. 
 
1.3. MAPK Signaling pathway 
The MAPK cascade is initiated by phosphorylations of MAPKs by the dual specific 
kinase MEKs. MEKs are phosphorylated and activated by MEK kinases (MEKK, e.g. 
Raf) that attracted to the plasma membrane by interacting with Ras superfamily 
GTPases
27
. MAPK signaling pathways process extracellular signals, such as 
environmental stresses and various cytokines, and promote various cellular functions 
including gene transcription. In mammals, five distinct groups of MAPKs were 
characterized; among them, the extracellular signal-regulated kinases (ERKs) 1 and 2, 
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p38 MAPKs (p38s) and c-Jun amino terminal kinases (JNKs) have been the most 
extensively studied
28
.  
1.3.1. ERK 1 &2  
ERK 1 (p44) and ERK 2 (p42) play crucial roles in regulating cell proliferation, cell 
differentiation and cell survival. Activation of ERK is typically mediated through the 
transmembrane receptor tyrosine kinases (RTKs) that are activated by various cytokines 
and growth factors, called mitogens. Mitogens stimulate autophosphorylation of RTKs 
and lead to the recruitment of the guanine nucleotide exchange factor SOS (Son of 
sevenless). SOS promotes conversion of GDP-bound inactive to GTP-bound active RAS 
(GTP-Ras)
27
.  GTP-Ras then interacts with the downstream serine/threonine kinase Raf 
(MEKK). Activated Raf phosphorylates and activates MEK1 & 2 to promote the 
activation of ERK1 & 2
27
. 
1.3.2. p38 
p38 is involved in various macrophage and neutrophil functions, including respiratory 
burst activity, chemotaxis, granular exocytosis, adherence and apoptosis, and mediates T-
cell differentiation and apoptosis by regulating gamma interferon production
29
. Four 
isoforms of p38 MAPK have been identified and δ), and p38 and p38 are 
ubiquitously expressed. MEK4 represents a site of integration for the p38 and JNK 
pathways. While MEK6 activates all p38 isoforms, MEK3 is somewhat selective for 
p38 and p38 isoforms30. The specificity in p38 activation is initiated by the formation 
of functional complexes between MEK3/6 and different p38 isoforms, and the selective 
recognition of the activation loop of p38 isoforms by MEK3/6. Activation of p38 results 
from the MEK3/6-catalyzed phosphorylation of a conserved Thr-Gly-Tyr (TGY) motif in 
p38 activation loop
29
.  
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1.4.  LeTx and pyroptosis 
1.4.1.  LeTx and NOD-like receptors 
LeTx causes rapid cell death of macrophages from certain strains of in-bred mice. 
Macrophages derived from mice including 129s/j, C3H/Hej and BALB/c undergo rapid 
cell death within 5 hours of LeTx exposure; whereas, macrophages derived from DBA/2, 
AKR, and C57BL/6 mice undergo slow apoptotic cell death, likely due to inactivation of 
MEKs
31, 32
. Genetic studies on these mice identified the nucleotide oligomerization 
domain (NOD)-like receptor & pyrin domain –containing protein (NLRP1b, Gene ID: 
637517, also known as NALP1b) responsible for the rapid cell death
33
. NLRP1b is a 
member of the NOD-like receptor (NLR) family and is highly polymorphic. To date, five 
polymorphic NLRP1b alleles have been described in mice
33
. It was shown that only 
macrophages harboring a LeTx-sensitive allele undergo rapid cell death by LeTx.  
NLRs are a family of intracellular pattern recognition receptors that recognize various 
microbial components and endogenous danger associated molecular patterns
34
. Upon 
activation, all NLRs known to date form heterogeneous multimeric oligomers, termed 
inflammasomes, that are composed of NLRs, pro-caspase-1 and ASC (apoptosis-
associated speck-like). The multi-protein platforms facilitate auto-cleavage of pro-
caspase-1 into highly active caspase-1. Caspase-1 then cleaves the proinflammatory 
cytokines, pro-interleukin (IL)-1 and -IL-18 into biologically active IL-1 and IL-18, 
respectively, and induces rapid cell death termed “pyroptosis”35. Inflammasomes play a 
role for immune cells in discriminating non-virulent and virulent  pathogens
35
; in 
response to bacterial virulence factors including type III and IV secretion systems (T3SS 
and T4SS), inflammasome, NLRC4 (also known as IPAF)  is activated through NLR 
signaling, leading to activation of caspase-1. NLRs act as an intracellular pattern 
recognition sensor for danger signals in the cytoplasm
36
. Among the 23 members of the 
NLR family in human, only several NLRs have been explored for their function and 
activators. Besides NLRP1 activated by LeTx, NLRP3 is activated by microbial pore 
forming toxins, crystalline uric acid or uric acid crystals, and extracellular ATP. NLR 
family CARD domain-containing protein 4 (NLRC4, also known as IPAF) senses the 
presence of flagellin and plays important roles in innate immune responses to gram 
 7 
 
negative bacteria
37
. Several cellular events were commonly shown to be required for their 
activation, including lysosomal membrane disruption, K+ efflux and reactive oxygen 
species (ROS) generation
38
.  However, the exact molecular mechanisms of NLR 
activation are largely unknown.  
1.4.2.  LeTx and pyroptosis 
The molecular mechanism of NLRP1b activation by LeTx is yet to be defined. Several 
recent studies have shown that NLRP1b undergoes auto- and LF-dependent cleavages, 
which is required for its activation
39, 40
. It was speculated that the cleavage allows the 
formation of  NLRP1b inflammasome through forming a caspase activation and 
recruitment domain (CARD) homotypic interaction with procaspase-1
41
. After NLRP1b 
activation, caspase-1 plays an integral role in LeTx-induced pyroptosis; however, how 
caspase-1 induces pyroptosis is also enigmatic
42
. Pyroptosis is a caspase-1-dependent 
type of cell death triggered by microbial pathogens, including anthrax lethal toxin, 
Salmonella spp. Shigella spp, and Listeria spp
43, 44
 and various danger-associated 
molecular patterns.  In the process of pyroptosis, DNA damage occurs and its process is 
caspase dependent
45
.  Caspase-1 is activated during pyroptosis by a large supramolecular 
complex termed the pyroptosome , which is largely composed of dimers of the adaptor 
protein ASC (also known as an inflammasome)
46
. Pyroptosis results in the release of 
pathogen associated molecular patterns (PAMPs) and cytokines that activate pro-
inflammatory immune cell mediators
47
. In the process of pyroptosis, cell lysis occurs 
upon the formation of pores in the cell membrane, which disrupts the cellular ionic 
gradient, leading to an increase in osmotic pressure followed by cell swelling and 
bursting. At the same time, the cytosolic contents release via the channels of the pores
48
. 
Subsequently, caspase-1 cleaves pro-inflammatory cytokines, resulting in activation. 
Moreover, DNA cleavage with retained integrity and nuclear condensation has been 
associated with the process.  Several cellular events are reported to be required for LeTx-
induced pyroptosis, including early mitochondrial dysfunction
49, 50
 , lysosomal 
permeablization
51
, Ca
2+
influx 
52, 53
, and generation of reactive oxygen species (ROS) 
54
. 
However, whether these events are required for caspase-1 activation or downstream of 
caspase-1 activation is still to be examined. We previously showed that LeTx causes 
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distinct characteristics of mitochondrial dysfunction from those by NLRP3, which is 
dependent on NLRP1b/caspase-1 and at least in part mediated through the three 
mitochondrial cell death genes: Bcl2 adenovirus E1B-interacting protein 3 (BNIP3) and 
BNIP3-like (BNIP3L) and metastatic lymph node 64 protein (MLN64)
50, 55
.  
1.4.3. The mitochondrial cell death proteins BNIP3 & BNIP3L   
Early mitochondrial dysfunction induced by LeTx in LeTx-susceptible macrophages has 
been documented by us
50, 55
 and others
49
. LeTx causes a loss of mitochondrial membrane 
potential and mitochondrial succinate dehydrogenase activity. Mitochondrial impairment 
and pyroptosis by LeTx requires proteasome activities, and the proteasome inhibitor 
MG132 prevented the mitochondrial dysfunction
49
. Our studies have also shown that 
LeTx causes mitochondrial dysfunction, manifested by early hyperpolarization, followed 
by rapid depolarization, ROS generation and depletion of free glutathione
55
. In addition, 
the mitochondrial cell death proteins BNIP3 and BNIP3L were also involved in the 
mitochondrial dysfunction. However, the molecular mechanisms of these proteins in 
inducing mitochondrial dysfunction are still unknown. 
BNIP3 was first discovered 1994 in a yeast two hybrid screen using a B cell cDNA 
library as one of three novel proteins that interact with the adenovirus E1B19K protein
56
. 
BNIP3 predominantly localizes to the mitochondria
56, 57
, where it is integrated into the 
mitochondrial membrane through its transmembrane N-terminal regions
56
 . Previous 
studies suggested that BNIP3 is a weak inducer of cell death that cause loss of 
mitochondrial hyperpolarization, opening of the Mitochondrial Permeability Transition 
Pore (MPTP), and  release of cytochrome c 
58
. Overexpression of BNIP3 induces loss of 
mitochondrial membrane and cell death. However, the exact mechanism of how BNIP3 
disrupts mitochondrial function is still elusive. It has been reported that BNIP3 
expression is increased under hypoxic conditions and regulated by the transcription factor, 
hypoxia-inducible factor 1(HIF-1)
59, 60
. BNIP3 is a key regulatory gene in hypoxia-
induced cell death
61, 62
. In addition, increased expression of BNIP3 leads to cell death in 
cardiac myocytes and other cultured cell lines. BNIP3L is a homolog of BNIP3 (also 
called NIX) and localizes to the nuclear envelope, endoplasmic reticulum, and 
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mitochondria. BNIP3L activates downstream effectors Bax/Bak through interacting with 
anti-apoptotic Bcl-2 and Bcl-XL
63
.   
BNIP3 and BNIP3L are also known to be involved in autophagy. Daido et al. first 
described a role for BNIP3 in autophagy in the ceramide-induced autophagic death of 
malignant glioma cells
64
. In these cells, ceramide induced an increase in BNIP3 
expression, and BNIP3 causes mitochondrial depolarization and autophagy. In an 
ischemia-reperfusion model, BNIP3 induced autophagy, which protected HL-1 myocytes 
from cell death
65
. Similarly, hypoxia-induced BNIP3 increased autophagic death, but 
protected Saos2 cells from necrosis-type cell death
66
. Thus, BNIP3 and BNIP3L exhibit a 
dual function; they induce cell death, and they also participate in the induction of 
autophagy. 
Expression of BNIP3 and BNIP3L was also known to be epigenetically modified in 
various colon carcinoma and hematopoietic cell lines. Murai et al. reported that 
methylation of the 5’CpG islands of BNIP3 was correlated with silencing of the gene in 
colon carcinoma line
67
. Treatment of BNIP3 with azacitidine restored expression of 
BNIP3 mRNA and protein, leading to cell death. In addition, acetylation of histone H3 in 
5′ region of the BNIP3, is correlated with gene expression and inversely with DNA 
methylation in a hematopoietic cell line
68
.  
 
1.5. Cellular adaptation of macrophages to LeTx-induced pyroptosis 
We and others showed that macrophages pre-exposed to sub-lethal doses of LeTx are 
refractory to subsequent high cytolytic doses of LeTx. This phenomenon is termed toxin 
induced resistance (TIR)
50, 69
. Salles et al. showed that macrophages, such as RAW 264.7 
and J774A.1 cells, exposed to a low dose of LeTx become resistance to subsequent high 
doses of LeTx for 4 days
69
. We further showed that a small portion of TIR cells (2-4%) 
retain TIR characteristics for up to 5 to 6 weeks. These TIR cells show no defect in in 
cleaving MEKs in response to LeTx treatments, suggesting that uptake of LeTx into the 
cytoplasm is normal 
50
.  For the mechanism of TIR, an adaptive ERK activation by a 
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MEK-independent process or a general decrease in proteasome activity was suggested
69
. 
Since ERK has not yet been shown to be protective in pyroptosis, its involvement in TIR 
is not clear. Proteasome activity was shown to be required for LeTx-induced caspase-1 
activation and pyroptosis
49
.  However, we showed that TIR cells are also normal in 
activating NLRP1b and caspase-1 in response to LeTx, suggesting that the decrease of 
proteasome activity may be responsible for TIR at most in part.  
A genome-wide micro-array study compared mRNAs between wild-type and TIR found 
that expression of BNIP3 and BNIP3L were significantly down regulated in TIR cells 
(Fig 1.1)
50
.  Furthermore, we have shown that TIR cells are mainly resistant to NLRP1-
inflammasome-induced mitochondrial dysfunction, including mitochondrial inner-
membrane hyperpolarization, generation of reactive oxygen species and depletion of the 
anti-oxidant glutathione
55
. However, to date, how BNIP3 and BNIP3L are down 
regulated in TIR cells is elusive.  
 
 
 
 
 
 
 
 
 
 
 
 11 
 
 
 
 
 
 
 
 
 
 
Fig 1.1. Sequence of cellular events involved in LeTx-induced cell cycle arrest and 
pyroptosis. 
LF released from endosome causes mitochondrial dysfunction which requires Bnip3 and 
Bnip3L, resulting in cell death, known as pyroptosis. LF also cleaves MEKs, resulting in 
cell cycle arrest. Arrow () indicates activation.  
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1.6.  Epigenetics                                                                                            
The term, ‘epigenetics’ (epi, επί in Greek, means over, above or outer), literally implies 
‘outside conventional genetics’  and is used to describe stable alteration in gene 
expression or cellular phenotype caused by mechanisms other than changes to the DNA 
nucleotide sequence
70
. DNA methylation and histone modifications are two types of 
epigenetic mechanisms that regulate gene expression without altering the underlying 
DNA sequence. Other epigenetic mechanisms such as ubiquitination, phosphorylation, 
and sumoylation have been studied for histone modification. Epigenetic changes may be 
sustained through cell divisions for the remaining life of the cell and may also last for 
multiple generations of cells
71
. 
1.6.1. DNA methylation and regulation of gene expression 
DNA methylation is a mechanism which methylates cytosine residues at specific 
positions in the DNA molecule, resulting in repression of gene transcription
72, 73
.  DNA 
methylation is involved in key biological processes including differentiation, imprinting, 
and X chromosome inactivation
70
 . Failure to maintain proper DNA methylation results 
in developmental disorders as well as cancer
74
. CpG sites are regions of DNA where 
a cytosine nucleotide locates next to a guanine nucleotide in the linear sequence of bases. 
These sites are the main locations where most DNA methylation occurs. Methylation of 
CpG dinucleotide is catalyzed by DNA methyltransferases (DNMTs), which transfers the 
methyl moiety from the methyl donor S-adenosylmethionine to the 5’ position of the 
cytosine ring. There are three main DNA methyltransferases (DNMTs; DNMT3a, 3b and 
DNMT1). DNMT3a and 3b are required for de novo methylation, whereas DNMT1 is 
involved in the maintenance of DNA methylation patterns from parental to progeny 
cells
75
 and has a preference for methylating hemimethylated DNA 
72, 76
. DNMT1 is a 195 
kDa nuclear protein that harbors the DNMT catalytic domain in its C terminus and there 
are several regulatory domains in the N terminus, which are the DNA methyltransferase 
associated protein 1 (DMAP1)-binding domain, the Replication Foci Targeting Sequence 
(RFTS) domain, the CxxC zinc binding domain and two Bromo-Adjacent Homology 
(BAH) domains. Thirteen alternating repeats of Gly-Lys residues link the regulatory with 
the catalytic domain
77
. For repression of genes, the most critical signal is initiation of 
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repression by DNA itself. Methyl groups bound to the cytosine residues situated 5’ to 
guanosines in DNA, so called CpG islands, are directly responsible for the recruitment of 
the HDAC complex via proteins such as methylated CpG binding proteins (MeCP2) and 
methyl CpG biding domain containing proteins (MBD), or via the enzymes that 
methylate the CpG islands, the DNA methyltransferase
78, 79
.  
1.6.2. Histone & Chromatin  
In the nucleus, DNA is wrapped around the four core histone proteins H3, H4, H2B, and 
H2A to form the nucleosome which is the fundamental repeating unit of chromatin
80
. 
These nucleosomes are condensed into higher order structures which form chromosomes. 
This is required for efficient packaging of DNA into the nucleus of the cell. When DNAs 
are compacted into the structure, its accessibility becomes greatly limited, and this serves 
as a mechanism by which the cell regulates DNA mediated processes such as 
transcription, DNA replication, and DNA repair
81, 82
. Each histone is composed of a 
conserved globular histone-fold domain, and extended N and C-terminal tails. The 
globular domains of the histone proteins form the nucleosome core, wrapped around by 
146 base pair-long DNAs. The extended histone tails protrude beyond the DNA and into 
the nucleoplasm. These tails serve as the sites of a variety of post-translational 
modifications, such as acetylation, methylation, ubiquitination and phosphorylation
81, 83
. 
The presence or absence of certain post-translational modifications allows localized de-
condensation or condensation of the chromatin. These localized changes in chromatin 
structure can exert positive or negative regulatory effects on DNA-mediated processes 
such as gene regulation, DNA repair and DNA replication
81, 82
  
1.6.3. Histone modifications and regulation of gene expression 
Histones can undergo multiple post-translational modifications, which mainly occur 
along their N-terminal tails
82
. The histones possess polypeptide amino-terminal tails rich 
in positively charged lysine residues that are attracted to the negatively charged DNA. 
Neutralization of the positive charges by acetylation promotes gene transcription. 
Genome-wide studies showed that various combinations of histone modifications in a 
specific genomic region can lead to the activation or repression of gene expression
84
. For 
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example, histone methylation or acetylation can play a key role in the maintenance of 
both active and suppressed states of gene expression, depending on the position of 
methylation. It was shown that trimethylation of lysines (K) positioned on 4, 36, or 79 on 
H3 (H3K4me3 , H3K36me3, and H3K79me3, respectively), monomethylation of H4K20 
and H2K5 (H4K20me and H2BK5me) , and acetylation of H3K9 and H3K14 result in 
gene activation, whereas di- or trimethylation of H3K9 (H3K9me2 and H3K9me3) and 
H3K27 (H3K27me3) lead to gene repression
82, 85
.  
1.6.3.1. Histone acetylation and gene expression regulation 
Acetylation neutralizes the positively charged lysine residues of the histone N-termini, 
decreasing their affinity for DNA, which cause nucleosome unfolding and increases 
access of transcription factor to the promoter
86
. Histone acetyl transferase (HAT) is an 
enzyme that acetylates conserved lysine amino acids or histone proteins by transferring 
an acetyl group from acetyl CoA to form ε-N-acetyl (Lysine amino acid of acetyl group). 
It neutralizes positively charged lysine residues, leading to reduction of affinity between 
histone and negatively charged DNA. Also it can acetylate non histone proteins, such as 
transcription factors and nuclear receptors to facilitate gene expression. Increased histone 
acetylation by HAT is a key feature of transcriptionally active chromatin and it is also 
integral to the histone assembly and cell replication mechanism
80
. HATs can be largely 
categorized into two classes
87, 88
. Type A HATs are localized in nuclei and most likely 
acetylate nuclesomal histones and transcriptional activation. By contrast, type B HATs 
can be purified from cytoplasmic fractions, and these activities are responsible for 
acetylating newly synthesized histone before chromatin assembly during DNA 
replication
80, 87
. Most HAT associated transcriptional coactivators contain bromodomains. 
Bromodomains bind to acetylated lysines with ligand selectivity because of 
conformational differences in the loops
89
. The CBP bromodomain specifically binds 
acetylated Lys382 in the COOH terminus of p53, which is responsible for co-activator 
recruitment by p53 after DNA damage
90
.  Gene expression is regulated by the balance of 
histone acetylation and deacetylation on lysine residues in the N-terminal tails. 
Disturbing the balance between HAT and HDAC may disturb gene transcription as well 
as DNA replication. 
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1.6.3.2. Histone deacetylase (HDAC) 
Histone deacetylases (HDACs) are enzymes that can remove acetyl groups from a ε-N-
acetyl (Lysine amino acid of acetyl group) on a histone so that histones can wrap DNA 
more tightly, leading to chromatin compaction and transcriptional repression
91
. Histone 
deacetlyation is considered to suppress the expression of several genes that regulate cell 
growth and differentiation. HDACs are divided into two subfamilies:  the Zn
2+
 dependent 
HDAC class (class I, II, and IV) and NAD (Nicotinamide adenine dinucleotide)+ 
dependent sirtuins (SIRT; class III). Class I HDACs, which show significant homology to 
the yeast protein RPD3, include HDAC 1,2,3,8, and 11 that are primarily nuclear and 
ubiquitously expressed, whereas class II HDACs include HDAC 4, 5, 6, 7, 9, and 10 
which are homologous to yeast HAD-1 like enzymes, and they are primarily localized to 
the cytoplasm but are known to shuttle in and out of the nucleus 
91
.  Class I HDACs are  
widely expressed and is found in most cell types, whereas class II HDACs appear to have 
more restricted distribution and may be involved in cellular differentiation
92, 93
. It is 
clearly known that HDAC enzymes usually operate along with other enzyme to silence 
genes. For taking these functions such as co-repression or chromatin remodeling, many 
proteins are recruited, result in repressor complex.  
1.6.3.3. DNA methylation and histone modification inter-relationship. 
Previously, several mechanisms were reported that DNMT1 and HDACs co-operatively 
work and induces silencing of genes
94, 95
. For example, Jones et al. suggested that 
methylated DNA and MeCP2 recruit HDACs, leading to gene silence
94
. Gene silencing 
can be caused by both histone deacetylation and methylation (Fig 1.2.), but the action of 
methylation is indirect and has no effect upon charge
86
. It also has been shown that 
methylation at a specific lysine residue (K4) in histone 3 is required for targeting histone 
tails for continuous acetylation and deacetylation
82
.  Valeria Santini et al. also suggested 
that action of methyl binding proteins and histone deacetylases, and the DNA structure 
changes to a compact, condensed chromatin configuration, result in permanent inhibition 
of messenger RNA and protein production
96
. Further, hypomethylating agents and 
histone deacetylase inhibitors act synergistically to restore functional gene expression.   
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Fig 1.2. Silencing gene expression by DNA methylation and Histone deacetylation 
DNA methyltransferases incorporate methyl group into cytosine residues of CpG 
dinucleotides. Histone deacetylases then bind to the methylated DNA and induce a closed 
configuration of chromatin. Transcription factors are dissociated from DNA and gene 
transcription is repressed
96
.    
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1.7.  Rationale, Hypothesis and Objectives 
TIR is a cellular phenomenon maintained throughout multiple cycles of cell division. 
Therefore, I hypothesized that TIR is mediated through epigenetic reprogramming. In 
order to address the hypothesis, the following objectives were proposed:  
1. Examining the effects of various chemical epigenetic inhibitors on TIR 
2. Examining whether specific DNA methylation and/or histone acetylation enzymes are 
involved in TIR 
3. Examining if epigenetic reprogramming regulates expression of BNIP3 and BNIP3L in 
TIR cells 
 
 
 
 
 
 
 
 
 
 
 21 
 
CHAPTER 2 - MATERIALS & METHODS 
2.1.   Cell culture & reagents 
RAW 264.7 murine macrophages were cultured in Dulbecco's modified Eagle's medium 
containing 8% heated-inactivated fetal bovine serum (Sigma-Aldrich), 10 mM MEM 
non-essential amino acids solution, 100 units/ml penicillin G sodium, 100 μg/ml 
streptomycin sulfate, and 1 mM sodium pyruvate. Cells were grown at 37°C in a 
humidified atmosphere of 5% CO2. 
Bone marrow-derived immortalized macrophages (BMDIM) from C57BL/6J mice were 
generated as described previously
90, 91
. Briefly, bone marrow cells were transfected with 
the J2 murine retrovirus, which carries the v-raf and v-myc oncogenes, and cultured for 7 
days in macrophage-driving medium containing macrophage colony-stimulating factor
91
. 
Cells were then cultured with normal medium (RPMI 1640 medium containing 10% heat-
inactivated fetal bovine serum, 10 mM MEM nonessential amino acids solution, 100 
U/ml penicillin G sodium, 100 μg/mL streptomycin sulfate, and 1 mM sodium pyruvate). 
TIR cells were generated as previously reported
45
. Briefly, RAW 264.7 macrophages 
treated with LeTx (500 ng/ml LF and 1g/ml PA) for 5 hours, and surviving cells were 
plated in a fresh cell  culture media . Two weeks later surviving clones were individually 
picked and plated on a 96-well plate. Each clone was duplicated, and tested for LeTx 
sensitivity, and LeTx resistant clones were pooled and propagated. 
Epigenetic inhibitors used in this study were as follows. For reagents, various epigenetic 
inhibitors, Aza-2-deoxycytidine (Sigma,Canada), Panobinostat (Selleck,Texas), 
Tozasertib (LC Lab, Boston), and Anacardic acid (Santa cruz biotech, California) were 
obtained from indicated sources. The antibody raised against N-terminus of MEK 1 was 
obtained from QED Bioscience Inc. Pan and specific antibodies raised against p38 
MAPK, ERK1/2, and MEK1 (COOH terminus of MEK1) were obtained from cell 
signaling technologies (Pickering, Ontario, Canada). Antibody raised against H3K27Ac 
was purchased from Active Motif, California.   
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2.1.1. Epigenetic inhibitor treatment   
For treatment of epigenetic inhibitors, stock solutions of Aza-2-deoxycytidine as a DNA 
methyl transferase inhibitor (DNMTi), Panobinostat as a Histone deacetylase inhibitor 
(HDACi), Tozasertib as a pan aurora protein kinase inhibitor, and Anacardic acid as a 
histone acetyl transferase (HAT) inhibitor were dissolved in DMSO. Wild type (RAW 
264.7 macrophage cells) and TIR cells were incubated with respective inhibitors at the 
indicated concentration and time.  
2.2.   Preparation of anthrax lethal toxin  
Protective antigen (PA) and lethal factor (LF) were purified as previously described
49
.  
Protective Antigen: PA was purified from the E. coli expression strain BL21 (DE3) 
bearing the plasmid construct (PET22B-PA). Overnight cultures were added to Luria 
broth containing ampicillin (50 g/mL). Cultures were grown with shaking at 37 ºC until 
OD 600 of 1.0 was reached. Isopropyl -D-1 thiogalactopyranoside (IPTG) was added to 
0.5 mM, and incubated with shaking at 30 ºC for additional 3-4 hours. Cells were 
harvested by centrifugation, re-suspended in a hypertonic solution with 30 mM Tris-HCl, 
pH 8.0, 20% sucrose, 1mm Ethylenediaminetetraacetic acid (EDTA) and incubated at 
room temperature for 10 min. Cells were pelleted again and resuspended in an isotonic 
solution with 20 mM of MgSO4 and incubated on ice for 30 min.                                     
Lethal Factor: LF was purified from Bacillus mageterium transformed with LF 
expressing plasmid (pWT-1520-LF). Overnight cultures were added to Luria broth 
containing tetracycline (10 mg/ml). Cultures were grown with shaking at 37ºC until OD 
600 of 0.3 was reached. Expression of LF was induced by adding 0.5% xylose into the 
culture and grown for an additional 8 hours. PA containing cell lysate and LF containing 
culture media were precipitated with 80% (NH4)2SO4, and the precipitated proteins were 
pelleted by centrifugation. The pellets were resuspended in 20 mM Tris-HCl (pH8.6) 
with 1 mM phenylmethanesulfonylfluoride (PMSF), and dialyzed using dialysis tubing 
30, 000 MWCO (Sigma). Samples were loaded onto a Q-Sepharose anion exchange 
column (Amersham) and proteins were isolated with an AKTA FPLC chromatography 
system (GE, USA). Active fractions were combined and dialyzed with PBS.   
 23 
 
2.3.   Cytotoxicity assay 
RAW 264.7 macrophages cells were cultured with or without LeTx in 96-well plates for 
5 hours, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was then 
added at a final concentration of 1 mg/mL. After incubating at 37 °C for additional 2 
hours, culture medium was carefully aspirated, and 100 μL of dimethyl sulfoxide was 
added to dissolve crystals. Optical densities of the wells were analyzed using micro plate 
reader at 570 nm. The ratio of cell survival was estimated based on the optical density of 
wells by comparison with non-treated cells as 100% survival.  
 
2.4.   Total cell lysate preparation and immunoblot analysis  
Total cell lysate extraction and Western blotting analysis was performed as previously 
described
31
. Briefly, cells were lysed in ice-cold cell lysis buffer (20 mM Tris-HCl 2 mM 
EGTA, 5 mM EDTA, 1 mM Na3VO4, 40 mM β-glycerophosphate, 30 mM sodium fluoride, 
20mM sodium pyrophosphate, pH7.2) containing 1% Triton X-100, and protease 
inhibitor mixtures (Roche Applied Science). Cell lysates were incubated on ice for 10 
min and then centrifuged at 12,500 rpm for 10 min at 4 ºC. These extracts were 
electrophoretically resolved in 10% SDS-PAGE gels, followed by transfer onto 
nitrocellulose membranes. Membranes were subsequently blocked at room temperature 
for 1 h with 5% (w/v) skim milk, and then incubated overnight at room temperature with 
antibodies. After extensive washing with TTBS ( 20 mM Tris pH 7.5, 150 Mm NaCl, and 
0.2% Tween 20), the secondary antibody was applied at 1:40, 000 dilution and incubated 
for 60 min. Exposure was performed and analyzed by Odyssey fluorescence imaging 
system (LI-COR Inc. USA).  
 
2.5.   Quantitative Real-time PCR (qPCR) 
Expression of mRNAs was quantified on a Rotor-Gene RG3000 quantitative multiplex 
PCR instrument (Montreal Biotech) using Express SYBR Green ER qPCR Super Master 
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Mix (Invitrogen). Briefly, total cellular RNA was isolated using TRIzol (Invitrogen) 
according to the manufacturer's instructions and then 2 g of total RNA was reverse 
transcribed using oligo (dT) primers and Moloney murine leukemia virus (M-MuLV) 
reverse transcriptase (New England Biotechnology).The amplification mix (20 μL) 
contained a cDNA template derived from 1g of total RNA, diluted to an amount of ~100 
ng of cDNA, 500 nM of each specific primer set, 10 μL Express SYBR Green ER qPCR 
master mix with ROX (Invitrogen), which contains dNTP, SYBR Green, hot-start fast 
Taq polymerase and buffer and DNase-free water. The PCR conditions were as follows: 
95 °C for 3min to activate hot start Taq polymerase, then 40 cycles of 95 °C for 15 sec, 
58 °C for 30 sec,72 °C for 25 sec final incubation at 83°C for 15sec. Fluorescence 
detection was performed immediately at the end of each annealing step.  
 
2.6.   Small interfering RNA transfection 
Small interfering RNA (siRNA) oligonucleotides directed against mouse DNMT1, and 
HDAC8 were purchased from Qiagen. Transfection of RAW 264.7 cell with siRNA was 
performed with Lipofectamine RNAi Max (Invitrogen) kit according to the 
manufacturer’s instruction. Levels of mRNA expression were confirmed by quantitative 
real-time PCR. Quantitative real time PCR Primers used for DNMT1, and HDAC8 are 
listed in Table 1.1. 
 
2.7.   Global DNA methylation analysis                                                        
Global DNA methylation was measured using the Methylamp Global DNA methylation 
quantification Kit (Epigentek, USA) as per the manufacturers’ instructions. The kit yields 
accurately measures the methylcytosine content as a percentage of total cytosine content. 
Briefly, 200 ng of genomic DNA was purified for cell samples using DNEasy blood and 
tissue kit (Qiagen) and then it was added to the strip well with high affinity to the DNA 
and incubated for 2 hours at 37ºC. The methylated fraction of DNA can be recognized by 
sequential incubation with 5-methylcytosine antibody for 1 hour at 37ºC, and secondary 
antibody for 1 hour at room temperature. A colorimetric reaction allowed to quantify 
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DNA methylation; the quantity of methylated DNA is proportional to the optical density. 
Optical densities of the wells were analyzed using micro plate reader at 450 nm. A 50% 
methylated DNA was used as a positive control and 0% methylated DNA was used as a 
negative control.   
5-mC % = (Sample OD – ME3 OD) ÷ S  x 100 
(ME4 OD – ME3 OD) x 2* ÷ P 
2.8.   Bisulfite sequencing  
2.8.1. Bisulfite genomic DNA sequencing 
Bisulfite treatment  For bisulfite-PCR, genomic DNA was purified from wild type 
(RAW 264.7 macrophage) and TIR cells using DNeasy Blood & Tissue Kit (Qiagen). 
Genomic DNA was treated with sodium bisulfite using Epitect bisulfite kit (Qiagen) as 
per the manufacturer’s instruction. In brief, 2 g DNA and 140 LEpitect bisulfite 
reaction buffers containing sodium bisulfite and protection buffer were mixed and 
modified by bisulfite mediated conversion in thermal cycler under the following 
condition: 99°C for 5 min, 60°C for 25 min; 99°C for 5 min, 60°C for 85 min; 99°C for 5 
min, 60°C for 170 min. Samples were then purified using EpiTect spin column and eluted 
with 20 μL Buffer EB.                                                                                                         
Bisulfite PCR, Bisulfite treated DNA was amplified using forward and reverse primers 
listed in Table 1.1. Bisulfite primer targeting CpG site was designed through Li lab meth 
primer site
92
 (http://itsa. ucsf.edu/~urolab/methprimer). The PCR was performed on a 
thermalcycler (Stratagene, La Jolla, CA) containing 200 µM dNTPs, 2 mM MgCl2, 0.3 
µM forward and reverse primers and 0.5 units of Taq polymerase (NEB). The PCR 
conditions were as follows: 95 °C for 3 min, then 33 cycles of 95 °C for 1 min, 55 °C for 
1 min and 72 °C for 1 min. A final incubation at 72 °C for 15 min concluded the PCR. 
PCR products were verified by gel electrophoresis and purified using gel purification.  
Bisulfite sequencing  For bisulfite-sequencing, the PCR products obtained with 
Bisulfite-PCR were cloned into PGEM-T easy vector cloning system (Promega) on LB-
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Ampicillin plate. After that, 5 clones were selected and the plasmid DNA was then 
purified using plasmid purification system (Bioscience Inc). Purified clones are 
sequenced using M13 by London Regional Genomic Center (London, Ontario, CA).  
2.8.2. Bisulfite pyrosequencing  
Bisulfite PCR Bisulfite pyrosequencing was used for quantitative methylation analysis of 
the mitochondrial cell death genes, BNIP3 & BNIP3L. For preparation of samples, 
genomic DNA from wild type and TIR cells were isolated with DNEasy blood & tissue 
kit (Qiagen Cat No 69504.) and then bisulfite conversion of the genomic DNA was 
performed with the EpiTect Bisulfite Kit (Qiagen Cat No. 59104). Methylation states of 
CpG’s were amplified using 20 ng of bisulfite-converted genomic DNA for two samples 
(wild type and TIR) and 0.2 µM of forward and reverse primers, one of which was 
biotinylated. PCR reactions were performed using the Pyromark PCR kit (Qiagen) 
optimized for bisulfite-treated DNA. PCR amplification of bisulfite-treated DNA was 
performed in 25 µL reactions containing 2 μL (1 U) Hot start Taq DNA polymerase 
(Qiagen), 2.5 μL 10X PCR buffer, 20 mM MgCl2, 0.5 μl 10 mM dNTP mix, 1.0 μL (10 
pmol) of each forward and reverse primers, 18 μL (∼100 ng) bisulfite treated template 
DNA and 18 μL PCR-grade water. PCR was carried out with an initial denaturation step 
at 95 °C for 5 min, 35 cycles of 95°C for 30 s, primer-specific annealing temperature 
(54 °C for BNIP3 & BNIP3L) for 30 s, elongation at 72 °C for 45 s and a final extension 
step at 72 °C for 5 min.  
Pyrosequencing & analysis Bisulfite pyrosequencing was performed on a PyroMark 
Q24 Pyrosequencing System with the PyroMark Gold Q24 Reagents Kit. Pyro Q-CpG 
software (Biotage, Uppsala, Sweden) was used for data analysis. To demonstrate if 
amplification was sufficient, samples were run on QIAXcel capillary electrophoresis  
2.9. Chromatin immunoprecipitation (ChIP) analysis  
30 million RAW 264.7 cells were cross-linked with 1% formaldehyde and lysed in Lysis 
buffer [50 mM Tris at pH 8.0, 5 mM EDTA, and 1% sodium dodecyl sulfate (SDS)] 
supplemented with protease inhibitors (Thermo Scientific). Chromatin was sheared by 
sonication (Bioruptor UCD-200 ultrasound sonicator from Diagenode) for 20 mins 
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resulting in DNA fragments between 150 and 200 bp in size. After centrifugation to 
remove cell debris at 12,500 rpm for 10 mins, 5% of the sample was kept as INPUT and 
then diluted 10 times in dilution buffer [50 mM Tris at pH 8.0, 0.5% Triton X-100, 0.1 M 
NaCl, and 2 mM EDTA] supplemented with protease inhibitors. The rest of the soluble 
chromatin fraction was recovered and precleared for 1 hour at 4ºC with a mixture of 
Protein A and G-conjugated Dynabeads (Invitrogen). Before immunoprecipitation, 50 L 
of Dynabeads protein G was incubated with 6 g of anti-H3K27Ac antibody (Active 
motif, California) or -IgG rabbit antibody (Sigma) for 2 hours at 4ºC to evaluate the 
presence of nonspecific interaction. Chromatin was immnoprecipitated overnight at 4º C 
with antibody-conjugated Dynabeads. The immunoprecipitates were extensively washed 
with the following combination of wash buffers (Each wash step was performed for 10 
mins); high salt RIPA buffer [10 mM Tris (pH 8.0), 500 mM NaCl, 1 mM EDTA, 1% 
TritonX-100, 0.1% SDS, 0.1% DOC, and protease inhibitor cocktail], LiCl wash buffer 
[10 mM Tris-HCl (pH 8.0), 250 mM LiCl, 1 mM EDTA, 0.5% NP40, and 0.5% DOC], 
and TE buffer [10 mM Tris-HCl (pH 8.0) and 1 mM EDTA]. Bound chromatin and input 
DNA were placed in elution buffer [10 mM Tris (pH 8.0), 5 mM EDTA, 300mM NaCl, 
and 0.5% SDS] and, heated overnight at 65ºC to reverse the cross-linking. After 
proteinase K digestion (100 μg, 1 hour at 50°C), DNA fragments were purified on 
QIAquick Spin columns (Qiagen) in 50 μL of EB (elution buffer) and then 1 μL of that 
was used in each quantitative real-time PCR analysis. Sequences of promoter-specific 
primers are available in listed table 1.1. Sequences of primers were designed to 
specifically amplify proximal promoter regions from the genes BNIP3 and BNIP3L. Data 
are presented as enrichment of the precipitated target sequence as compared to input 
DNA. 
 
2.10.  Statistical analysis  
Data are presented as Mean ± SE. Statistically significant differences were determined 
by unpaired student t-test using GraphPad software. 
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Table 1.1. List of primer sequences  
Gene Gene Primer sequence (5’→ 3’) 
Bisulfite-
sequencing 
BNIP3 F:5’-TGAAGTTAGGTTGGAGGTGGGTAGA-3’ 
R:5’-AACAAAAAAAACAAACTCAACACCCAAAAC-3’ 
 
 
 
 
 
 
 
 
 
 
Real time  
PCR 
BNIP3 F:5′-GCTCCCAGACACCACAAGAT-3′ 
R:5′-TGAGAGTAGCTGTGCGCTTC-3′ 
BNIP3L F:5′-CCTCGTCTTCCATCCACAAT-3′ 
R:5′-GTCCCTGCTGGTATGCATCT-3′ 
DNMT1 F:5’-AAGAATGGTGTTGTCTACCGAC-3’ 
R:5’-CATCCAGGTTGCTCCCCTTG-3’ 
DNMT3a F:5’-ATGTGGTTCGGAGATGGCAAG-3’ 
R: 5’ AGATGGCTTTGCGGTACATGG-3’ 
DNMT3b F: 5’-CCTGTGGAGTTTCCGGCTAC-3’ 
R: 5’- GACGCTCTTAGGTGTCACTTC-3’ 
HDAC1 F: 5’-TGAAGCCTCACCGAATCCG -3’ 
R: 5’-GGGCGAATAGAACGCAGGA-3’ 
HDAC2 F: 5’-GGAGGAGGCTACACAATCCG-3’ 
R: 5’-TCTGGAGTGTTCTGGTTTGTCA-3’ 
HDAC5 F: 5’-AGCACCGAGGTAAAGCTGAG-3’ 
R: 5’-GAACTCTGGTCCAAAGAAGCG-3’ 
HDAC8 F: 5’-ACGGGAAGTGTAAAGTAGCCA-3’ 
R: 5’-TCCACGTAGAGAATACGGTCAAA-3’ 
HDAC9 F: 5’-GAGAGGCATCGCAGAGAGC-3’ 
R: 5’-CCCACGGAATGATTCTTTCCA-3’ 
GAPDH F: 5′-GCATTGTGGAAGGGCTCATG-3′ 
R: 5′-TTGCTGTTGAAGTCGCAGGAG-3 
 
 
ChIP 
BNIP3 F: 5’-AATCTGTCCCTCAACGGCTG-3’                                               
R: 5’-GTTGGTAGATGCACCAGGCT-3’ 
BNIP3L F: 5’-TCTTCCTCCAGTCCTACCCA-3’ 
R: 5’-CCTGGGACAGTGTTAGCCTC-3’ 
GAPDH F:5′-GCTGACATCAACTCCCAGGT-3′ 
R:5′-TTCCGTTCTCAGCCTTGACT-3′ 
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CHAPTER 3 - RESULTS 
3.1    Obtaining and characterizing TIR macrophages.  
3.1.1.   Obtaining TIR macrophages.  
Although RAW 264.7 macrophages underwent cell death (~98%) by LeTx (500 ng/ml 
LF and 1g/ml PA for 24 h), a small population of the surviving macrophages (~4%) 
remained resistant even after 6 weeks of the initial LeTx treatment. Based on MTT assays, 
LeTx caused ~70% of cell death in wild type cells, but less than 20% in TIR cells in 5 
hours (Fig 3.1A). Cell death detected by LeTx was likely a pryroptotic cell death, since 
cell death was prevented by knocking down caspase-1 (Fig. 3.1B). 
3.1.2.   TIR cell has no defects in intracellular incorporation of LeTx.                       
To further examine if TIR cells had no defects in incorporating LeTx into the cytoplasm, 
we examined MEK1 cleavage and basal ERK and p38 activities inactivation in both wild 
type and TIR cells exposed to LeTx for 3 hours (250ng/ml LF & 500ng/ml PA). There 
was no apparent defect in MEK1 cleavage and dephosphorylation of ERK1 and 2, and 
p38 in TIR cells when compared with wild type cells (Fig 3.2). Since LeTx inhibited 
MEK cleavage leading to inhibition of the MAPK signaling cascade, cleavage of MEK1 
and basal ERK and p38 indicates that TIR cells have no defects in intracellular 
incorporation of LeTx.  
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Fig 3.1. TIR cells are resistant to LeTx-induced pyroptosis.  
(A) Both wild type (RAW 264.7 macrophage) and TIR cells were exposed to LeTx (LF 
500ng /ml,1g/ml PA) for 5 hours. Then cell death was measured using MTT assay. (B) 
Wild type cells were transfected with scrambled siRNA or siRNA targeting caspase-1 (si-
CASP1) for 48 hours. Cells were then treated with LeTx (500ng/ml LF and 1g/ml PA) 
for 5 hours and cell death was measured by MTT assay. Data are expressed as means and 
SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005. 
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Fig 3.2.  TIR cell has no defects in incorporating LeTx into the cytoplasm.                   
Wild type (RAW 264.7 macrophage) and TIR cells were exposed to LeTx (250ng of LF 
& 500ng of PA) for 3 hours. MEK N-terminal cleavage and phosphorylation of ERK1/2 
and p38 were analyzed using immunoblots.  p38 was used as loading control. Data are 
representative of two independent experiments. 
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3.2. TIR is mediated through an epigenetic mechanism(s). 
3.2.1. Inhibition of DNMT or HDAC sensitizes TIR cells to LeTx-induced pyroptosis.                                                      
Based on the observation that TIR was a phenomenon sustained for 6 weeks after initial 
treatments (~42 cycles of cell division), it is possible that an epigenetic mechanism(s) is 
involved in the TIR process. To examine its involvement, wild-type and TIR cells were 
treated with various chemical inhibitors targeting enzymes involved in epigenetic 
reprogramming processes: tozasertib  (broad spectrum aurora kinase inhibitor, 50nM), 
azacitidine (broad spectrum DNA methylasetransferase inhibitor, 2.0M), panobionstat 
(LBH-589, broad spectrum histone deacetylase inhibitor, 100nM), mocetinonstat (histone 
deacetylase inhibitor targeting HDAC1, 2, & 3: 50nM), and anacardic acid (broad 
spectrum histone acetyltransferase inhibitor 2.0M) for 24 hours. Different doses of each 
epigenetic inhibitors were decided based on dose dependent study (Fig 3.3D). Cells were 
then exposed to LeTx (500ng/ml LF & 1g/ml PA) for 5 hours and cell death was 
measured using MTT assay. Among the inhibitors examined, azacitidine and 
panobinostat significantly rendered TIR cells sensitive to LeTx-induced pyroptosis (Fig 
3.3A).These results suggest that DNA methylation and histone deacetylation are involved 
in TIR. Of note, mocetinostat had no effects on TIR, suggesting that HDAC 1, 2, and 3 
may not be involved in TIR maintenance. Furthermore, TIR cells were pretreated with 
azacitidine for various time points and sensitivity to LeTx was examined. As shown in 
Fig 3.3B, TIR cells became sensitive to LeTx in a time-dependent manner, completely 
regaining sensitivity to a similar level of wild-type cells in 48 hours. Panobinostat 
rendered TIR cells sensitive to LeTx in a dose-dependent manner and full LeTx 
sensitivity was reached at 100 nM concentration (Fig 3.3C).    
 
3.2.2.   LeTx induces global methylation in macrophages.       
Since the DNA methyltransferase inhibitor, azacitidine sensitized TIR cells to LeTx-
induced pryoptosis (Fig. 3.3A and B), I first examined whether LeTx induces global 
DNA methylation in macrophages. The levels of global methylation were measured using 
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an ELISA (Enzyme linked immunosorbent assay) with antibody raised against 
methylated CpG dinucleotide. Genomic DNAs were added to a specifically designed well 
for high affinity to DNA and anti-body for CpG dinucleotide and secondary antibody 
were subsequently added to read methylation level through optical density (O.D.).  The 
lowered concentration of LeTx (100ng/ml LF and 200ng/ml PA) for global methylation is 
treated because high concentration of LeTx (500ng/ml LF and 1g/ml) is cytotoxic dose 
and therefore it can kill most cells within 24hours. Wild type cells showed a very low 
level of global DNA methylation (~1%), which was substantially increased (~11%) in 
response to LeTx in a time-dependent manner (100ng LF/ml and 200ng PA/ml; Fig. 
3.4A). The global DNA methylation was decreased in azacitidine-treated samples, 
suggesting a role of DNA methyltransferases in the process. However, the increase of 
global DNA methylation was not maintained in TIR cells (Fig. 3.4C), also suggesting that 
global DNA methylation per se was not responsible for TIR. To examine the involvement 
of NLRP1b in global DNA methylation, macrophages originating from C57BL/6 mice 
harboring non-functional NLRP1b were treated with LeTx and global DNA methylation 
was analyzed. The macrophages showed higher levels of basal DNA methylation, which 
was further increased by LeTx (Fig. 3.4D). These results suggest that LeTx increased 
global DNA methylation independent of NLRP1b/caspase-1.  
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Fig 3.3. The DNMT and HDAC inhibitors sensitize TIR cells to LeTx-induced 
pyroptosis.  
(A) TIR cells were pretreated with 50nM tozasertib, 100nM panobinostat, or 2.0M 
azacitidine, 50nM Mocetinostat, and 2.0m Anacardic acid for 24 hours. The inhibitor 
doses were determined based on both dose-dependent studies with RAW 264.7 
macrophage cells and IC values reported in literatures97-99. Non-treated wild type (WT; 
RAW 264.7 macrophage), non-treated TIR or pre-treated TIR cells were newly seeded on 
96 plates and exposed to LeTx (500ng/ml LF and 1g/ml PA) for 5 hours. (B) TIR cells 
were cultured in the presence or absence of azactidine (2 ) for the times indicated. 
Non-treated WT, TIR or azacitinde pretreated TIR cells were exposed to LeTx (500ng/ml 
LF and 1mg/ml PA) for 5 hours. (C) TIR cells were cultured in the presence or absence of 
panobinostat for doses indicated overnight. Non-treated WT, TIR, or pretreated TIR cells 
were exposed to LeTx (500ng/ml LF and 1g/PA) for 5 hours (D) For dose dependent 
studies, TIR cells were cultured in the presence and absence of varied epigenetic 
inhibitors including Azacitidine, Anacardic Acid, Mocetinostat, and Tozasertib followed 
by LeTx (500ng/ml LF and 1g/PA) for 5 hours. (A-D) Cell death was measured using 
MTT assay. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** 
P≤0.005. 
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D) Dose dependent study  
I. Azacitidine  
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III. Anacardic Acid 
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Fig 3.4. Global DNA methylation levels in TIR were not different from those of wild 
type cells.  
(A) Genomic DNA was purified from wild type cells (WT: RAW 264. 7 macrophages) 
and wild type cells treated with LeTx (100ng/ml LF & 200ng/ml PA) for times indicated. 
(B) Genomic DNA was purified from wild type and wild type treated with LeTx (100ng 
LF/ml & 200ng PA/ml) for 24 hours, and wild type treated toxin for 24 hours and 
subsequently treated with 2.0M azacitidine overnight. (C) Genomic DNA was purified 
from wild type and TIR cells.  (D) Genomic DNA was purified from macrophages 
prepared from C57BL/6 mice (C57 cells) and C57 cells treated with LeTx (100ng/ml LF 
& 200ng/ml PA) for 24 hours. (A-D) Global methylation levels were measured using 
global methylation ELISA kit (Epigentek, USA), following the protocol provided by the 
manufacturer. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** 
P≤0.005 (student’s t-test). 
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3.2.3. DNMT1 is involved in the maintenance of TIR.  
Although global DNA methylation was not found to be related to TIR, DNA 
methyltransferase (DNMT) activity was required for maintaining TIR (Fig 3.3). To 
identify specific DNMTs involved in TIR, expression of DNMT1, DNMT3a, and 
DNMT3b was analyzed using real-time quantitative PCR (qPCR) analysis. As shown in 
Fig 3.5A, expression of DNMT1 was higher than 2-fold in TIR cells than wild type cells, 
but no significant changes were detected in the levels of DNMT3a and rather a slight but 
significant decrease of DNMT3b. Also, wild type cells were pretreated with LeTx for 
various time points, and mRNA levels of DNMT1 were examined. As shown in Fig 3.5B, 
mRNA of DNMT1 was increased in a time-dependent manner, suggesting that LeTx 
caused increase of DNMT1 and DNA methylation. These results suggest that DNMT1 
played a key role in TIR. To further confirm that the correlation between DNMT1 
expression and TIR, multiple TIR and wild type cell clones were examined for DNMT1 
expression. Consistent with the notion, expression of DNMT1 was closely related with 
cell death resistance by LeTx with correlation coefficient (R
2
=0.8) as shown in Fig 3.6. 
To functionally validate the role of DNMT1 in TIR, DNMT1 was knocked down using 
DNMT1-specific siRNAs in TIR cells (Fig 3.7A).  DNMT1-specific but not scrambled 
si-RNAs knocked down about 60% of DNMT1 mRNAs (Fig 3.7A) and sensitized TIR 
cells to LeTx (Fig. 3.7B). Global methylation was measured using genomic DNA 
purified from DNMT1 specific knocked down wild type followed by LeTx treatment for 
24 hours. Though LeTx-treated wild type showed a 5 fold increase in global methylation 
level, knock down of DNMT1 did not show an increase of methylation, suggesting that 
DNMT1 plays a role in global methylation induced by LeTx (Fig 3.7C).  
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Fig 3.5.  DNMT1 is up-regulated in TIR.  
(A) mRNAs from wild Type (RAW 264.7 macrophage) and TIR cells were collected and 
analyzed for the expression of DNMT1, DNMT3a, and DNMT3b, relative to GAPDH by 
quantitative real-time PCR. (B) mRNAs from wild type (RAW 264. 7 macrophage) and 
wild type treated with LeTx (100ng LF & 200ng PA) for times indicated were collected 
and analyzed for DNMT1 mRNA levels. Data are expressed as means and SD (n=3), * 
P≤ 0.05, **P≤0.01, and *** P≤0.005 (student’s t-test).  
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Fig 3.6. TIR is correlated with upregulation of DNMT1 expression.  Five TIR clones 
with different sensitivities and one wild type (RAW 264.7 macrophage) clone were 
analyzed for DNMT1 mRNA levels using quantitative real time PCR analysis. Cell death 
levels were measured using MTT assay after treating cells with LeTx (LF 500ng/ml, PA 
1g/ml) for 5 hours. Correlation between cell death and DNMT1 expression was 
calculated using the Graphpad program (R
2
= correlation coefficient). Data are expressed 
as means and SD (n=3).
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Fig 3.7. Inhibition of DNMT1 sensitizes TIR cells to pyroptosis.  
(A) Quantitative real time PCR analysis of siRNA knock down of DNMT1 in RAW 
264.7 cell. TIR cells were transfected with scrambled or DNMT1 targeting (si-DNMT1) 
siRNAs for 48 hours. Treated cells were processed for total RNA purification and cDNA 
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were 
normalized by the GAPDH expression levels in each sample. (B) TIR cells were 
transfected with scrambled or DNMT1 targeting siRNA (si-DNMT1) for 48 hours 
followed by treatment with LeTx (500ng/ml LF and 1g/ml PA) for 5 hours. Cell death 
was then measured by MTT. (C) Wild type (RAW 264. 7 macrophage) were transfected 
with scrambled siRNAs or siDNMT1 for 48 hours and then treated with LeTx (100ng LF 
& 200ng PA) for 24 hours. Global methylation rates of surviving cells were then 
measured. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** 
P≤0.005 (Student’s t-test). 
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3.2.4. HDAC8 is involved in maintenance of TIR.  
Following up the chemical inhibitor experiments (Fig 3.3), expression of various HDACs 
including HDAC1, 2, 5, 8, and 9 were analyzed using qPCR. Among them, HDAC8 and 
9 were up-regulated more than 2 fold in TIR cells, whereas HDAC 1, 2, and 5 were 
down-regulated (Fig. 3.8). These results suggest that HDAC 1, 2 and 5 were not involved 
in TIR maintenance, which is consistent with the HDAC 1, 2 and 3 inhibitor mocetinostat 
results that showed no effects on TIR cells (Fig 3.3A). When multiple LeTx-sensitive and 
resistant clones were examined for HDAC8 expression levels, a strong correlation 
between expression of HDAC8 and TIR phenotypes (R
2 
=0.79) was shown.  
 
To further confirm the role of HDAC8 in TIR, HDAC 8 was knocked down with 
HDAC8-specific si-RNAs and examined for LeTx sensitivity.  As expected, HDAC8-
specific si-RNA down-regulated HDAC8 expression and TIR cells knocked down 
became sensitive to LeTx-induced pyroptosis but not in scrambled si-RNAs (Fig3.10A & 
B). Global methylation was measured using genomic DNA purified from HDAC8 
specific knocked down wild type cells followed by LeTx treatment for 24 hours.   
Though LeTx treated wild type showed a 5 fold increase in global methylation level, 
HDAC8 knockdown did not show an increase in methylation, suggesting that HDAC8  
also plays a role in global methylation induced by LeTx (Fig 3.10 C). 
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Fig 3.8. HDAC8 & HDAC9 are upregulated in TIR.    
mRNAs from wild type (RAW 264.7 macrophage) and TIR cells were collected and 
analyzed for HDAC1, 2, 5, 8, and 9 by quantitative real-time PCR. Data are expressed as 
means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (Student’s t-test).  
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Fig 3.9. TIR is correlated with HDAC8 upregulation. Five TIR clones with different 
sensitivities and one wild type (RAW 264.7 macrophage) clone were analyzed for 
HDAC8 mRNA levels using quantitative real time PCR analysis. Cell death levels were 
measured using MTT assay after treating cells with LeTx (LF 500ng/ml, PA 1g/ml) for 
5 hours. Correlation between cell death and HDAC8 expression was calculated using the 
Graphpad program (R
2
= correlation coefficient). Data are expressed as means and SD 
(n=3). 
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Fig 3.10. Inhibition of HDAC8 sensitizes TIR cells to pyroptosis.  
(A) Quantitative real time PCR analysis of siRNA knock down of HDAC8 in RAW 
264.7 cells. TIR cells were transfected with scrambled or HDAC8 targeting (si-HDAC8) 
siRNAs for 48 hours. Treated cells were processed for total RNA purification and cDNA 
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were 
normalized by the GAPDH expression levels in each sample. (B) TIR cells were 
transfected with scrambled or HDAC8 targeting si-RNAs (si-HDAC8) for 48 hours, 
followed by treatment with LeTx (500ng/ml LF and 1g/ml PA) for 5 hours. Cell death 
was then measured by MTT. (C) Wild type cells (RAW 264.7 macrophage) were 
transfected with scrambled siRNA or si-HDAC8 for 48 hours followed by treatment of 
LeTx (100ng LF & 200ng PA) for 24 hours. Global methylation rates were measured for 
each sample. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** 
P≤0.005 (Student’s t-test).  
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3.3. Down-regulation of BNIP3 & BNIP3L is mediated through DNMT1 
and HDAC8.  
3.3.1. DNMT1 is involved in the down regulation of BNIP3& BNIP3L in TIR cells. 
We previously documented that TIR is in part mediated by down-regulation of BNIP3 
and BNIP3L
50
. Indeed, TIR cells expressed BNIP3 and BNIP3L to 40% of the levels 
expressed in wild type cells (Fig 3.11). TIR cells treated with azacitidine (2.0M 
Azacitidine for 24 hours) significantly up-regulated expression of both BNIP3 and 
BNIP3L at the mRNA levels up to 10- and 15-folds, respectively, (Fig 3.12). Similarly, 
knocking down DNMT1 by siDNMT1 up-regulated expression of BNIP3 (~8-fold) and 
BNIP3L (20-fold) in TIR cells (Fig 3.13), suggesting that methylation by DNMT1 is 
involved in down regulation of BNIP3 and BNIP3L.  
3.3.2. Methylations in CpG Islands of BNIP3 & BNIP3L are not involved in TIR.   
To examine whether TIR cells harbor higher levels of methylation in CpG islands of 
BNIP3 and BNIP3L, both conventional bisulfite sequencing and pyro-sequencing 
methods were used. Bisulfite treatment is most commonly used method to identify 5 
methyl cytosine, m (5)-c, which is methylated cytosine by DNA methyltransferase. This 
experimental approach is based on the principle that methylation happened on the 
cytosine residue of dinucleotide CpG, and treatment of DNA with bisulfite deaminated 
cytosine, producing unmethylated cytosine residues to urasile, but left 5-methylcytosine 
residues unaffected as cytosine
100
.This, by PCR, is converted to thymine. The final result 
is the creation of an artificial single nucleotide polymorphism (C, if methylated, and T if 
not methylated) that can be analyzed using several common sequencing techniques
101
.  
After bisulfite treatment, one of the CpG islands identified in the gene encoding BNIP3 
was amplified and sequenced using a conventional cloning method as previously 
described in methods section (Section 2.8.1). Sequencing five of the clones from wild 
type and TIR cells showed no methylation in the CpG island of BNIP3 (Fig 3.14B). 
Pyroassay is a powerful sequencing method which detects nucleotide incorporation by 
proportional emission of light in each pyrosequencing cycle
102, 103
. For methylation 
analysis, biotin labeled, single stranded PCR products generated from bisulfite-treated 
DNA were used as a template with an internal primer
104
.  Pryoassay can quantify 
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methylation frequencies in CpG islands and distinguish between methylated and 
unmethylated sequences. I prepared genomic DNA from wild type RAW 264.7 
macrophage and TIR cells and Qiagen conducted bisulfite treatment followed by 
pyroassay. In line with the previous conventional bisulfite sequencing results, bisulfite 
pyroassay showed that 13 consecutive positions in longest CpG Islands of BNIP3 and 
BNIPL in wild-type and TIR cells were mostly unmethylated and no apparent differences 
were detected (Fig 3.15). However, the size for bisulfite sequencing for both 
conventional and pyroassay is limited up to 400 bp as upper limit due to DNA 
fragmentation which can occur during the bisulfite treatment
101
. In addition, the high 
redundancy of the target sequence due to the original GC richness creates long stretches 
of thymines, which are often difficult to read for the polymerases
105
. Hence, extensive 
regions of CpG islands in BNIP3 and BNIP3L which can be more than 1000 bp long are 
still to be sequenced. 
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Fig 3.11. Bnip3 and Bnip3L are down regulated in TIR.  mRNA expressions of (A) 
BNIP3 and (B) BNIP3L were analyzed relative to GAPDH by using real time 
quantitative PCR in wild Type (RAW 264.7 cells) and TIR cells. Data are expressed as 
means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (student’s t-test).  
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Fig 3.12. The DNA methyltransferase inhibitor azacitidine induces BNIP3 & 
BNIP3L expression in TIR cells. Wild Type (RAW 264.7 macrophage) and TIR cells 
were pretreated with 2.0M azacitidine for 24 hours and mRNA levels of (A) BNIP3 and 
(B) BNIP3L relative to GAPDH were measured by real-time PCR. Data are expressed as 
means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (Student’s t-test).  
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Fig 3.13. Knocking down DNMT1 by siRNA enhances BNIP3 and BNIP3L 
expression in TIR cells.  
(A) Quantitative real time PCR analysis of siRNA knock down of DNMT1 in RAW 
264.7 cell. TIR cells were transfected with scrambled or DNMT1 targeting (si-DNMT1) 
siRNAs for 48hrs. Treated cells were processed for total RNA purification and cDNA 
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were 
normalized by the GAPDH expression levels in each sample (B) TIR cells were 
transfected with scrambled siRNAs or DNMT1 targeting siRNAs (si-DNMT1) for 48 
hours and expression of BNIP3 and BNIP3L were analyzed by real time quantitative 
PCR. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 
(Student’s t-test).  
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Fig 3.14. CpG islands of BNIP3 was not methylated.                                                    
(A) The CpG islands of BNIP3 were identified using epigenomic tools from NCBI
106
. (B) 
Genomic DNAs were purified from wild type and TIR cells and treated with bisulfite. 
PCR was conducted with the bisulfite specific primers and sequences of amplicons 
(125bp) were analyzed using bacterial cloning method as previously described in the 
method section (Section 2.8.1). Open and closed circles respectively represent 
unmethylated and methylated CpG dinucleotides (Black circle: methylated, White circle: 
unmethylated), respectively (N=5) (C) Sequence information of amplicon after untreated 
and treated bisulfite treatment for both wild type and TIR cells were identified.  
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Bisulfite sequencing of CpG Island of BNIP3 (125bp)   
 
 
 
 
 
 
 
 71 
 
 
 
C) 
 
 
 
 
 
 
 
 
 
 72 
 
 
 
 
 
 
Fig 3.15.  Pyroassay analysis of methylated BNIP3 & BNIP3L                           
Bisulfite pyroassay was conducted to analyze methylation status of 13 consecutive 
positions in CpG islands of (A) BNIP3 & (B) BNIP3L. (C) Methylation levels were 
calculated using Pyro Q-CpG software. The assays were performed by Qiagen (Maryland, 
USA). 
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C) 
Table 3.1. Bisulfite pyroassay results of BNIP3 & BNIP3L  
  Metyhlation (%) 
Gene Type Position No. 
1 2 3 4 5 6 7 8 9 10 11 12 
BNIP3 WT 5.84 4.92 3.19 1.96 3.92 2.45 3.67 2.65 6.94 3.57 9.32 2.53 
TIR 5.35 4.25 2.70 2.43 2.95 3.41 4.35 2.79 5.43 2.90 9.27 2.56 
BNIP3L WT 2.79 7.42 2.98 3.27 2.15 6.16 2.4 2.18 2.22 3.12 3.93 1.96 
TIR 2.97 7.67 3.27 2.93 2.04 6.37 1.98 2.32 2.03 3.31 4.26 1.67 
Positive 
Ctrl 
WT 3.11 8.13 3.07 3.73 1.53 4.33 2.58 2.20 1.99 3.49 4.52 1.54 
Meth* 98.4 100 91.2 99.4 86.5 100 89.3 84.6 85.2 100 97.5 NA 
*: Methylated positive control  
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3.3.3. HDAC8 is involved in the down-regulation of BNIP3 & BNIP3L in TIR cells.   
HDAC8 expression was increased in TIR cells (Fig 3.8) and knocking it down by 
siRNAs sensitized TIR cells to LeTx-induced pyroptosis (Fig 3.10). Therefore, I 
examined whether knocking down HDAC8 enhanced BNIP3 and BNIP3L expression in 
TIR cells.  As expected, TIR cells treated with HDAC8 targeting siRNAs induced a 14 
fold and 30-fold higher expression of BNIP3 and BNIP3L, respectively, than those of 
non-treated TIR cells (Fig 3.16). Collectively, together with the previous DNMT1 
knocking down (Fig 3.11), down-regulation of BNIP3 and BNIP3L in TIR cells was 
likely mediated through epigenetic mechanisms involved in both DNA methylation and 
histone deacetylation.  
3.3.4. Deacetylation at histone 3 lysine 27 (H3K27) is involved in down regulation of 
BNIP3 & BNIP3L expression.  
Since HDAC8 was shown to be involved in TIR and suppression of BNIP3 and BNIP3L, 
histone acetylation could have been involved in TIR maintenance. To find targets of 
HDAC8 responsible for BNIP3 and BNIP3L expression, acetylated histones binding to 
BNIP3 and BNIP3L encoding gene were searched through the genome-wide epigenetic 
marker database
107
 (ENCODE) and we found that histone H3 acetylated at lysine 27 
(H3K27Ac) was shown to be commonly involved in expression of both BNIP3 and 
BNIP3L
107
(Fig 3.17). Indeed, Western blot analysis using H3K27Ac-specific antibodies 
showed 5-fold higher levels of overall H3K27Ac immunoreactivity in wild type than TIR 
cell extracts (Fig 3.18). Also, treatments of panobinostat (100nM) showed a 9 fold 
increase and treatment of azacitidine (2.0M) showed a 12 fold increase in H3K27Ac 
levels compared to non-treated TIR (Fig 3.18). These results collectively suggest that TIR 
cells suppress BNIP3 and BNIP3L through deacetylating and methylatng H3K27, which 
at least in part renders resistance to LeTx-induced pyroptosis in TIR cells. In addition, 
ChIP (Chromatin Immunoprecipitation) assay showed that H3K27Ac was enriched in 
wild type whereas it is down regulated in TIR for BNIP3 expression, suggesting that 
H3K27Ac functions as an enhancer for the expression of BNIP3 (Fig 3.19A) through 
histone modification. However, enrichment of H3K27Ac in wild type did not show 
significant difference compared to TIR for BNIP3L expression (Fig 3.19B), suggesting 
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that other enhancers such as H3K9Ac or H3K36Ac or histone methylation of H3K4Me3 
are involved to regulate expression of BNIP3L.  
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Fig 3.16. Knocking down HDAC8 by siRNAs enhances BNIP3 & BNIP3L 
expression in TIR cells. 
 (A) Quantitative real time PCR analysis of siRNA knock down of HDAC8 in RAW 
264.7 cell. TIR cells were transfected with scrambled or HDAC8 targeting (si-HDAC8) 
siRNAs for 48 hours. Treated cells were processed for total RNA purification and cDNA 
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were 
normalized by the GAPDH expression levels in each sample (B) TIR cells were 
transfected with scrambled siRNAs or HDAC8 targeting siRNAs (si-HDAC8) for 48hrs 
and expression of BNIP3 and BNIP3L were analyzed by real time quantitative PCR. Data 
are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (Student’s 
t-test).  
 
 
 
 
 
 
 
 
 
 78 
 
A) 
 
B) 
 
 
S
c
ra
m
b
le
 T
IR
T
IR
+
s
iH
D
A
C
8
0 .0
0 .5
1 .0
1 .5
H
D
A
C
8
 m
R
N
A
(F
o
ld
)
  **
* *
T
IR
 
B
N
IP
3
B
N
IP
3
L
0
1 0
2 0
3 0
4 0
m
R
N
A
(F
o
ld
)
  **
*
                     T IR + s iH D A C 8
***
*
 79 
 
 
 
 
 
 
 
 
 
Fig 3.17. Histone modification profiles of H3K27Ac which interact with BNIP3 and 
BNIP3L. Histone modification site search using ENCODE
107, 108
, the signal of H3K27Ac 
targeting (A) BNIP3 and  (B) BNIP3L where histone modification occur were identified 
in the promoter region (Arrow → indicates primer design site for ChIP assay). Snap shot 
of from UCSC genome browser was taken showing for GC %, CpG islands, Chip-Seq for 
histone modification for the bone marrow derived macrophage cell line (BMDM).  
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Fig 3.18. Histone modification site for down regulation of BNIP3 gene expression in 
TIR (A) Expression of H3K27Ac in wild type (RAW 264.7 macrophage) and TIR were 
analyzed using immunoblots. -actin was used as loading controls.  (B) TIR cells were 
pretreated with histone deacetylase inhibitor (100 nM Panobinostat: PN) or DNA 
methyltransferase (2.0 M Azacitidine: Aza) inhibitor and levels of H3K27 acetylation in 
wild type and TIR were analyzed using immunoblots. Immunoreactivity of H3K27Ac 
was analyzed using NIH image program. Data are representative of three independent 
experiments. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** 
P≤0.005 (Student’s t-test).  
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Fig 3.19. H3K27Ac binding to the promoter regions of BNIP3 is suppressed in TIR. 
Promoter binding of the BNIP3 and BNIP3 to H3K27Ac was evaluated by Chromatin 
Immunoprecipitation (ChIP) analysis. Genomic DNAs from wild type (RAW 264.7 
macrophages) and TIR cells were prepared, sonicated, and, immunoprecipitated using 
antibodies against H3K27Ac, and control IgG. Immunoprecipitated  DNAs were 
analyzed by quantitative real-time PCR using primers for (A) BNIP3 and (B) BNIP3L. 
For ChIP efficiency, % of input DNA recovered by immunoprecipitation, was determined 
by quantitative real-time PCR. Rabbit IgG serum was used as a background control. 
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CHAPTER 4 - DISCUSSION 
Epigenetic reprogramming is a cellular mechanism of gene regulation persisting 
throughout cell division. Here, I showed that toxin induced resistance (TIR) was an 
epigenetic adaptation of macrophages to LeTx-induced pyroptosis. Previously, several 
mechanisms of TIR were suggested. Salles et al. reported an adaptive ERK activation by 
a MEK-independent process or a general decrease in proteasome activity was known to 
be partially involved
69
. We previously have found that BNIP3 and BNIP3L were down 
regulated in TIR
50
, conferring resistance to pyroptosis. Further, TIR cells were resistant 
to NLRP-1 inflammasome induced mitochondrial dysfunction, including mitochondrial 
inner membrane hyperpolarization, generation of reactive oxygen species (ROS), and 
depletion of the anti-oxidants
55
. However, specific mechanism how BNIP3 and BNIP3L 
were down regulated in TIR cells is still elusive and the mechanism needs to be further 
explored. In this study, we reported that DNMT1 and HDAC8 were required for 
maintaining TIR and it suppresses BNIP3 and BNIP3L in TIR. Also, H3K27Ac was 
decreased in TIR cells and it subsequently suppresses BNIP3. A previous study showed 
that LeTx inhibits histone H3 phosphorylation on serine 10 (H3S10) and suppresses IL-8 
production
109
. It was speculated that the cleavage of MEKs by LeTx, resulting in their 
inactivation, is responsible for the lack of H3S10 phosphorylation, since the 
phosphorylation is mediated by the mitogen and stress-activated kinase (MSK) which is 
activated by p38 and ERKs. However, since TIR cells were normal in basal p38 and ERK 
activities (Fig 3.2), H3S10 phosphorylation is expected to be normal in TIR cells. This 
study detected a significant and rapid increase of global DNA methylations by LeTx 
treatments (Fig 3.4A), which was prevented by the DNMT inhibitor azacitidine and 
siRNAs targeting DNMT1 (Fig 3.4B &D). These results suggest that up-regulation of 
DNMT1 was responsible for at least in part of global DNA methylation induced by LeTx. 
Global DNA methylation was also detected in macrophages harboring non-functional 
NLRP1b (Fig 3.4D), suggesting that activation of NLRP1b was not involved in the 
changes. Other studies have also shown that LeTx inhibits phosphatidylinositol 3-kinase 
(PI3K) and protein kinase B (Akt) signaling cascades
110
. As mentioned earlier, high 
global DNA methylation by LeTx was not maintained in TIR cells (Fig 3.4C) and thus 
global DNA methylation  per se was not likely involved in TIR. Interestingly, TIR cells 
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expressed a higher level of DNMT1 than those of wild type and the extent of LeTx-
induced pyroptosis was negatively correlated with the levels of DNMT1 expression (Fig 
3.6). These results suggest that DNA methylation at specific genome sites through 
DNMT1 was required for TIR maintenance; however, the identities of the genes are 
unknown. 
Since DNMT1 was required for TIR, I further examined whether BNIP3/BNIP3L 
expression in TIR cells could be restored by the DNMT chemical inhibitor azacitidine 
and siRNAs targeting DNMT1. Indeed, suppression of BNIP3 and BNIL3L expression in 
TIR cells required at least in part DNMT1-mediated DNA methylation (Fig 3.3 & 3.7). 
However, DNA methylations in the promoter regions encoding BNIP3 and BNIP3L were 
not different between wild type and TIR cells (Fig 3.14). Considering the limits of this 
study in the number of bisulfite sequence analysis performed using the conventional 
cloning method (Fig 3.14B) and partial sequence by the pyroassay (Fig 3.15). In addition, 
suppression of BNIP3/BNIP3L by DNMT1 could have been mediated through 
suppression of other genes that positively regulate BNIP3/BNIP3L expression.  
In addition to DNMT1, experiments with chemical inhibitors for enzymes involved in 
epigenetic reprogramming indicated that HDACs were required for maintaining TIR (Fig. 
3.3). Also the broad spectrum HDAC inhibitor panobionostat, but not HDAC1,2 and 3-
specific mocentinostat, rendered TIR cells sensitive to LeTx-induced pyroptosis (Fig.3.3), 
indicating that HDACs other than HDAC1,2, and 3 were required for TIR, Furthermore, 
qPCR analysis showed that HDAC8 and HDAC9, but not HDAC1, 2 and 5, were up-
regulated in TIR cells. TIR cells became sensitized to LeTx-induced pyroptosis when 
HDAC8 was specifically knocked down by siRNAs. Collectively, these results suggested 
that HDAC8 was involved in the resistance mechanism of TIR cells. HDAC8 is a 
member of the class I histone deacetylase family. It forms transcriptional repressor 
complexes by associating with many different proteins (including pRb-E2F and mSin3A), 
and plays an important role in transcriptional regulation, cell cycle progression, and 
developmental events. HDAC8 also may play a role in smooth muscle cell contractility
111
. 
Gao et al. reported that knockdown of HDAC8 resulted in the increased expression of 
JAK2/STAT signaling leading to cytokine signaling in K562 and HEL cells
112
.  
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Histone modification by HDAC and histone methylases can suppress BNIP3/BNIP3L 
expression. Given that DNA methylations in the promoter regions of BNIP3 and BNIP3L 
were not involved, histone acetylation levels could have contributed to their gene 
expressions in TIR cells. Several studies have elucidated that BNIP3 expression is 
regulated by epigenetic mechanisms such as DNA methylation and histone deacetylation 
and how transcription factor, Hypoxia Inducible Factor (HIF-1) influences expression of 
BNIP3 under hypoxic conditions
68, 92, 113-115
. For example, Murai et al. showed that 
BNIP3 expression was suppressed in hematopoietic tumors and it could be restored by 
the treatments of methyltransferase inhibitor, azacitidine
68
, leading to hypoxia-mediated 
cell death. When they measured the acetylation of histone H3 in the 5’ region of the gene 
using ChIP assays, gene expression was correlated with acetylation and inversely 
correlated with DNA methylation, suggesting that DNA methylation in the 5’ CpG 
islands and histone H3 deacetylation responsible for silencing BNIP3 expression
68
. 
Previously, several studies demonstrated that DNMT1 and HDACs co-operatively work 
and induce gene silencing
94
. For example, Jones et al. suggested that methylated DNA 
assembled into chromatin and it binds to the transcription repressor MeCP2 as a 
methylation-specific transcriptional repressor, which recruits Sin3 histone deacetylase 
complex
94
.   
By using HDAC inhibitors in vitro system, several effects on the expression of many 
genes have been shown, resulting in cell differentiation, inhibition of proliferation and 
induction of apoptosis
92, 112, 115
. Underlying mechanism of HDAC inhibitors affecting on 
gene expression is described as acetylation, resulting in increased recruitment of 
transcription factors, which result is increased in expression of particular genes. However, 
HDACs can render gene suppression through targeting non-histones. For example, Zhou 
et al. showed that inhibition of HDAC1 increased ubiquitin-dependent proteasomal 
degradation of DNMT1, suggesting that HDACs is directly involved in regulation of 
DNMT1 stability
116
. Further Du et al. suggested that DNMT1 was destabilized by 
acetylation driven ubiquitination, through targeting DNMT1 for proteasomal degradation. 
On the other hand, HDAC1 and deubiquitinases such as HAUSP (Herpes virus associated 
ubiquitin specific protease) stabilized DNMT1
117
.   
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Since HDAC8 was shown to be required for TIR, I further examined how histone 
deacetylation could influence BNIP3 and BNIP3L expression. Based on the ENCODE 
genome-wide epigenetic reprograming data base search
107
, H3K27Ac was identified as a 
common enhancer for both BNIP3 and BNIP3L expression (Fig 3.17). Through Western 
blots and chromatin immunoprecipitation assay (ChIP), I examined whether H3K27Ac 
was decreased in TIR cells. As expected, the levels of H3K27Ac were substantially 
diminished in TIR cells, and TIR cells exposed to the HDAC inhibitor panobinostat or 
DNMT inhibitor azacitidine restored H3K27Ac levels (Fig 3.18). ChIP assays using 
H3K27Ac specific antibodies showed that H3K27Ac strongly interacted with the 
promoter regions of BNIP3 but not BNIP3L in wild-type cells, which was significantly 
diminished in TIR cells (Fig 3.19A). These results suggest that H3K27Ac is possibly 
deacetylated by HDAC8, and resulted in the suppression of BNIP3 expression in TIR 
cells. Unlike BNIP3, occupancy of H3K27Ac of the BNIP3L promoter was about 10 fold 
less in both wild type and TIR than those of BNIP3 (Fig 3.19B), suggesting that 
H3K27Ac did not sufficiently present in the promoter region of BNIP3L (Fig 3.19B). I 
speculate that histone acetylation of H3K27 in BNIP3L promoter region less frequently 
occurs and histone deacetylase will not be recruited to down regulate expression of 
BNIP3L. Though, H3K27Ac minimally contributed expression of BNIP3L, other histone 
modifications such as histone methylation and acetylation of other regions such as 
H3K9Ac or H3K36Ac may be involved. The ENCODE genome-wide epigenetic 
reprograming data base search also identified H3K9Ac and H3K36Ac as histone 
modification marker for BNIP3 and BNIP3L gene expression in leukemia cell line, 
respectively
107
. It has been previously reported that acetylation of H3K36 and H3K9 
leads to activation of gene transcription as enhancer
118, 119
. It also has been shown that 
histone methylation enhances gene transcription; it is possible that mono methylation of 
H3K4 and H3K9, and tri methylation of H3K4 in BNIP3L activate gene transcription
120
.  
Examining the role of these acetylation sites of H3 in BNIP3 and BNIP3L expression will 
need to be further explored and it will provide insights into the mechanism of HDAC8 in 
TIR.  
In summary, TIR cells induced high levels of DNMT1 and HDAC8 expression, which 
was responsible for maintaining TIR and suppressing expression of the cell death genes 
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BNIP3 and BNIP3L (Fig 4.1), conferring resistance in TIR cells. Although the 
mechanism of DNMT1 in TIR was undetermined, HDAC8 could have suppressed the 
expression of BNIP3 through deacetylating histones such as H3K27Ac. This study for the 
first time elucidates epigenetic mechanisms of TIR cells in macrophage.  
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Fig 4.1. BNIP3 and BNIP3L are down regulated through epigenetic mechanism 
mediated via DNMT1 and HDAC8. LeTx induces methylation in RAW 264. 7 
macrophage cells and TIR and BNIP3 and BNIP3L partially methylated in TIR.  LeTx 
subsequently recruits HDAC8, leading to down regulation of BNIP3 and BNIP3L. (Blue 
indicates unmethylated DNA and red indicates methylated DNA.) 
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4.1. Further study 
This study provided valuable information on the role of epigenetic reprograming in TIR. 
However, multiple limitations were also identified in this study. To further elucidate the 
mechanisms of TIR, the following experiments are suggested:  
4.1.1. Validation of methylation status of BNIP3 and BNIP3L by genome sequencing  
Methylation of BNIP3 and BNIP3L should be confirmed through complete genome 
sequencing to overcome limitation of bisulfite sequencing. In the present study, BNIP3 
and BNIP3L were not methylated (Fig 3.14B & 3.15). However, use of bisulfite 
sequencing also has some limitation and it is not sufficient to completely cover CpG 
island, which is longer than 400bp
121
. Because DNA fragmentation can occur during the 
bisulfite treatment, amplicon size for both bisulfite genomic sequencing and pyroassay is 
limited up to ~400 and 500bp. In addition, the high redundancy of the target sequence 
due to the original GC richness creates long stretches of thymines, which are often 
difficult to read for the polymerases. This problem can be overcome by complete genome 
sequencing through next generation sequencing (NGS) and it may provide conclusive 
answers for the questions. Using the Illumina sequencing, I foresee that results in this 
study will be precisely confirmed.  
4.1.2. Indirect suppression of BNIP3 and BNIP3L by PI3K/Akt  
In the present study, the sequence of unmethylated BNIP3 and BNIP3L showed that 
direct DNA methylation did not occur (Fig 3.14 & 3.15). As previously mentioned, this 
methylation should be validated. However, if the validation result does not show that 
CpG islands of BNIP3 and BNIP3 are not methylated, it is possible to approach this 
matter with indirect down regulation of BNIP3 by activation of PI3K/Akt pathway. It was 
reported that NF-B activation located downstream signaling pathway of PI3K/Akt is 
crucial for the silencing of BNIP3 through E2F1-dependent gene transcription
114
. Also, 
we previously reported that activation of PI3K/Akt leads to cell cycle recovery from cell 
cycle arrest induced by LeTx in human acute monocytic leukemia cell line, THP-1 cell
122
. 
The linkage between cell cycle recovery via PI3K/Akt activation and toxin induced 
resistance mechanism by down regulation of BNIP3 & BNIP3L should be examined. It 
 96 
 
will provide insight how Akt activation by LeTx leads to activation of NF-B, resulting 
in suppression of BNIP3 and BNIP3 in TIR.  
4.1.3. Mechanism of recruitment between methylated BNIP3/BNIP3L by DNMT1 & 
HDAC8 
Mechanism showing how DNMT1 and HDAC8 cooperatively act together for 
suppression of BNIP3 and BNIP3L should be examined in depth. We have found that 
DNMT1 and HDAC8 are involved in down regulation of BNIP3 and BNIP3L (Fig 3.13, 
3.16 & 3.18). We should decipher the underlying mechanism how DNMT1 cooperatively 
interacts with HDAC8 for the repression of transcription, leading to silence of BNIP3 and 
BNIP3L. It has been reported that methylated DNA in chromatin binds to the 
transcription repressor proteins, MeCP2 and MBD2, which in turn recruit histone 
deacetylase, and forms histone deacetylase complex, leading to repression of genes
94, 95
. 
For this goal, I suggest that increased expression of MBD and MeCP2 in TIR should be 
examined using quantitative real time PCR. Also, immunoprecipitation will allow us to 
examine if methylation of BNIP3 and BNIP3L or other possible cell death genes by 
DNMT1 in TIR will bind to MeCP2 and MBD2 and subsequently recruits histone 
deacetylase complex. At the same time, it should be examined that if HDAC8 are 
recruited to this histone deacetylase complex.     
4.1.4.   Roles of HDAC8 and HAT for BNIP3/ BNIP3L expressions in histone 
modification 
For histone modification, the present study showed that H3K27Ac as an enhancer was 
down regulated in TIR, leading to down regulation of BNIP3 based on Western Blot & 
ChIP assay (Fig 3.18 & 3.19). However, the specific link between HDAC8 and 
H3K27Ac for histone modification was not yet specifically addressed in this study. 
Though it was shown that broad spectrum HDAC inhibitor, panobinostat restored 
expression of H3K27Ac (Fig 3.18), we should also conduct further experiment to 
determine if specific knock down of HDAC8 will lead to expression of H3K27Ac. In 
addition, since BNIP3L expression was not affected by H3K27Ac, we should further 
examine that BNIP3L expression was affected by other histone modification enhancers 
such as H3K79Ac and H3K36Ac or histone methylation of H3K4me. 
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We also found that other histone deacetylase 9 (HDAC9) showed a 2.5 fold increase in 
TIR (Fig 3.8). In this study, we examined only HDAC8, which showed highest 
expression. However, we should examine if expressions of HDAC9 is correlated with 
resistance of TIR. If so, we should further examine if HDAC9 down regulates BNIP3 and 
BNIP3L. 
In terms of histone acetyl transferase (HAT), it is elusive if TIR cells will gain sensitivity 
through HAT, leading to up-regulation of BNIP3 and BNIP3L. Therefore, we should 
examine if acetylation of H3K27 by CBP (CREB binding protein)/ P300 protein which 
has intrinsic histone acetyltransferase activity, will subsequently lead to increased 
expression of BNIP3 and BNIP3L in TIR (Fig 4.1).  
4.1.5.   Effect of histone methylation on BNIP3/BNIP3L expression   
Histone methylation is the modification of certain amino acids such as Lysine or 
Arginine in a histone protein by addition of one, two, or three methyl groups
123
. Histone 
methylation induces either transcriptional repression or activation. It was shown that 
trimethylation of lysines (K) positioned on 4, 36, or 79 on H3 (H3K4me3, H3K36me3, 
and H3K79me3, respectively), monomethylation of H4K20 and H2K5 (H4K20me and 
H2BK5me) result in gene activation, whereas di- or trimethylation of H3K9 (H3K9me2 
and H3K9me3) and H3K27 (H3K27me3) lead to gene repression
82, 85
. Trimethylation of 
H3K4 (H3K4me3) was identified in BNIP3L through ENCODE site and it may lead to 
activation of BNIP3L; Activation of H3K4me3 may lead to restoration of down regulated 
BNIP3L by HDAC8. Further ChIP assay and Western blot will allow us to examine if 
expression of BNIP3 and BNIP3L are affected by histone methylation.  
4.2. Therapeutic potential 
For the treatment of Anthrax, current therapy is limited to antibiotics such as 
ciprofloxacin or doxycycline. In addition, the antibiotic treatment cannot be effective in 
the case of inhalation infection; it can be 45% lethal even with treatment of antibiotics. 
Though anthrax vaccine is available in the U.S military against bioterrorism, the vaccine 
use for public is limited. Because it should be administered four times per year 
accompanying with an annual booster, this can be a complicated procedure for patients 
 98 
 
and because of that, it can cause delay in the immunization schedule. At this moment, it 
is not clear whether inducing TIR in macrophages or other cells is beneficial for the host 
in anthrax. NLRP1b was shown to be required for early detection B. anthracis and 
preventing anthrax in a mouse B. anthracis spore infection model
40
. The beneficial effect 
of NLRP1b is likely due to early release of IL-1 and IL-18, which induces early 
inflammatory responses during infection. However, in situations when antibiotics are 
already in place, overt inflammation may not be beneficial for the host and thus 
preventing NLRP1b activation could be beneficial. In addition, LeTx can be detrimental 
to host considering that LeTx enhances dissemination of bacteria beyond the draining 
lymphoid tissue, which could be mediated through pyroptosis. It was also shown that 
LeTx-induced cytotoxicity in mice and rats is detrimental for the hosts
33, 124
. Therefore, 
tailed therapies, preventing pyroptosis without affecting the IL-1 and IL-18, could be an 
ideal approach for treating anthrax. Further studies elucidating the mechanism specific 
for pyroptosis will provide new opportunities for developing novel interventions for 
anthrax.  
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